(NHI) National Health Investors - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US63633D1046
NHI: Sale-Leasebacks, Joint Ventures, Financing
National Health Investors, Inc. (NYSE: NHI), incorporated in 1991, operates as a real estate investment trust (REIT) focused on healthcare and senior housing properties. The company specializes in structuring investments through sale-leaseback transactions, joint ventures, and mortgage and mezzanine financing. Its portfolio includes independent living communities, assisted living and memory care facilities, skilled nursing centers, and specialty hospitals, primarily catering to the growing demand for age-related healthcare services. NHIs investments are diversified across need-driven and discretionary senior housing, ensuring a balanced exposure to both essential and elective care segments. The company has established a strong presence in over 20 states, with a portfolio exceeding 240 properties, generating consistent cash flows through long-term leases with healthcare operators. Web URL: https://www.nhireit.com
Exchange: NYSE
Type: common stock
Country Origin: United States
GICS Sub Industry: Health Care REITs
3 Month Forecast:
Additional Sources for NHI Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NHI Stock Overview
Market Cap in USD | 3,538m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 1991-10-09 |
NHI Stock Ratings
Growth Rating | 50.9 |
Fundamental | 44.7 |
Dividend Rating | 38.8 |
Rel. Strength | 5.53 |
Analysts | 3.88/5 |
Fair Price Momentum | 78.18 USD |
Fair Price DCF | 92.16 USD |
NHI Dividends
Dividend Yield 12m | 4.89% |
Yield on Cost 5y | 9.41% |
Annual Growth 5y | -3.99% |
Payout Consistency | 93.8% |
NHI Growth Ratios
Growth Correlation 3m | 84% |
Growth Correlation 12m | 32.4% |
Growth Correlation 5y | 55% |
CAGR 5y | 14.52% |
CAGR/Max DD 5y | 0.46 |
Sharpe Ratio 12m | 1.36 |
Alpha | 17.44 |
Beta | 0.370 |
Volatility | 21.78% |
Current Volume | 166.2k |
Average Volume 20d | 230.4k |
As of May 02, 2025, the stock is trading at USD 75.37 with a total of 166,178 shares traded.
Over the past week, the price has changed by +0.07%, over one month by +1.48%, over three months by +11.06% and over the past year by +24.91%.
Partly, yes. Based on ValueRay Fundamental Analyses, National Health Investors (NYSE:NHI) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 44.70 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NHI as of May 2025 is 78.18. This means that NHI is currently overvalued and has a potential downside of 3.73%.
National Health Investors has received a consensus analysts rating of 3.88. Therefor, it is recommend to buy NHI.
- Strong Buy: 3
- Buy: 1
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, NHI National Health Investors will be worth about 84.8 in May 2026. The stock is currently trading at 75.37. This means that the stock has a potential upside of +12.56%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 80.9 | 7.3% |
Analysts Target Price | 79.6 | 5.6% |
ValueRay Target Price | 84.8 | 12.6% |